Financial Performance - The company recorded a net loss of $222.187 million for the three months ended September 30, 2025, compared to a net loss of $77.686 million in the same period of 2024 [632]. - Total operating expenses for the three months ended September 30, 2025, were $172.588 million, significantly higher than $3.763 million in the same period of 2024, largely due to asset impairment and increased operational costs [632]. - Revenue for the three months ended September 30, 2025, increased by $28 thousand (311.1%) to $37 thousand compared to $9 thousand in the same period of 2024, primarily due to higher automotive sales revenue [634]. - For the nine months ended September 30, 2025, revenue increased by $103 thousand (33.9%) to $407 thousand compared to $304 thousand in the same period of 2024, driven by $37 thousand in automotive sales and $370 thousand in leasing revenue [635]. - The company reported a $138.5 million impairment loss related to long-lived assets for the three months ended September 30, 2025, primarily due to updated operational plans and production forecasts [660]. - The company has an accumulated deficit of $4,671.5 million and an unrestricted cash balance of $62.9 million as of September 30, 2025 [690]. Research and Development - Research and development expenses are expected to increase as the company focuses on the FF 92 and FX Series vehicles, following substantial completion of R&D for the FF 91 [620]. - Research and development expenses for the three months ended September 30, 2025, increased by $1.5 million (28.2%) to $6.640 million compared to $5.180 million in the same period of 2024, driven by higher operating consumables and equipment rental costs [640]. - The company is focusing on final validation and production readiness of the FX Super One vehicle, with ongoing R&D efforts aimed at enhancing vehicle performance and safety systems [641]. Product Development and Launch - The FF 91 series is currently being manufactured at the FF ieFactory California, with ongoing limited deliveries while reallocating resources towards the FF 92 upgrade and FX Super One development [575]. - The FX Super One is designed as the first "First Class AI-MPV," targeting a new market segment with advanced AI features and a goal of delivering "twice the performance at half the price" [575]. - The planned FF 92 upgrade program is in the research and development stage and aims to maintain the company's competitive edge in the ultra-luxury electric vehicle segment [575]. - The FX Super One features advanced AI technologies, including a voice interaction system based on large language models [577]. - The company commenced deliveries of the FF Series, specifically the FF 91 model, and is preparing for full-scale production of the FX Series, including the Super One model [691]. Market Strategy and Expansion - The company has established operations in the UAE to support assembly and sales for FF 91 series vehicles, further expanding its presence in the Middle East [566]. - The company has implemented a dual-home market strategy, integrating U.S. technological innovation with China's supply chain capabilities [569]. - The company is exploring potential manufacturing opportunities in China through joint ventures or other arrangements [565]. - The company aims to leverage its Eco Artificial Intelligence (EAI) mobility ecosystem with blockchain initiatives to create new value channels for users and investors [569]. - The company is expanding its U.S. and Middle East operations, with its Ras Al Khaimah facility ready for occupancy to support FX Super One production [577]. Financing and Capital Management - The Company secured approximately $105 million in new cash financing in July 2025, primarily through unsecured convertible notes and warrants [581]. - The Company raised over $100 million in total capital since September 2024 [585]. - The company expects to fund ongoing operations through various financing alternatives, including equipment financing and equity offerings, until sufficient revenue is generated from product sales [604]. - The anticipated start of FX Series production is expected to generate new revenue streams and enhance operational performance [701]. - The company projects substantial additional funds will be required to continue operations and support production of the FF 91 and FX Series vehicles [701]. Compliance and Governance - The company regained full compliance with Nasdaq's listing requirements in September 2025 [589]. - The Board approved the issuance of up to 61.9 million shares of Class A Common Stock under the March 2025 Securities Purchase Agreement [585]. - The Company confirmed it will not pursue a reverse stock split unless required for Nasdaq compliance [585]. - The company qualifies as a "smaller reporting company" and is not required to provide certain market risk disclosures [728]. Inventory and Revenue Recognition - The company recorded approximately $7.1 million in inventory reserve additions for the three months ended September 30, 2025, increasing the total inventory reserve from approximately $2.8 million in 2024 to approximately $14.2 million in 2025 [637]. - Customer deposits amounted to $4.1 million as of September 30, 2025, up from $3.0 million as of December 31, 2024, reflecting an increase in vehicle reservations driven by the launch of the FX Super One vehicle [613]. - The company recognizes revenue from automotive sales upon delivery, with payments typically received at that point [607]. - Deferred revenue related to products and services was insignificant as of September 30, 2025 [616]. Accounting Estimates and Risks - Management's estimates for financial statements are based on historical experience and reasonable assumptions, affecting reported amounts of assets and liabilities [723]. - Actual results may differ significantly from management's estimates due to changes in accounting estimates and current global macroeconomic conditions [724]. - Critical accounting estimates involve significant estimation uncertainty and may materially impact financial condition or results of operations [725]. - No major changes to critical accounting estimates have occurred that materially impact the financial statements as of the report date [726].

Core Viewpoint - Faraday Future's subsidiary AIxCrypto Holdings Inc. has officially completed its name change and is now listed under the new stock code AIXC, marking a significant strategic shift for the company [1][3]. Group 1: Strategic Developments - The company aims to create a global leading ecosystem that integrates AI, cryptocurrency, and blockchain, linking Web2 and Web3, with the goal of becoming the primary entry point into the AI Web3 world [3][4]. - AIxC has introduced a new three-pronged business strategy, which includes BesTrade DeAI Agent & Web3 AI terminal, RWA&EAI Ecosystem Development, and crypto asset AI management [6][7]. Group 2: Financial Implications - The first project under the RWA business will involve the tokenization of FFAI's stock, with plans to purchase $5 million worth of FFAI shares through an independent third party, aiming to achieve lower-cost financing compared to Web2 [3][6]. - AIxC is expected to provide five major reverse empowerment benefits to FFAI, including financing, asset enhancement, technological and business empowerment, user expansion, and valuation enhancement [7][9]. Group 3: Innovation and Growth - The company has demonstrated a rapid incubation capability, successfully launching new businesses in a short time, which validates its ability to innovate continuously across various sectors, including vehicles and technology [9]. - FFAI is focusing on developing an EAI ecosystem and is set to achieve significant milestones, including the launch of its first vehicle in the U.S. by the end of the year and the delivery of its first vehicle in the Middle East on November 27 [9].

Core Viewpoint - Faraday Future's subsidiary AIxCrypto Holdings Inc. has officially completed its name change and is now listed under the new stock code AIXC, marking a new strategic chapter for the company [1][3]. Group 1: Strategic Developments - The company aims to create a global leading ecosystem that integrates AI, cryptocurrency, and blockchain, linking Web2 and Web3 [3][4]. - AIxC has introduced a new three-pronged business strategy, focusing on Web3 trading, ecosystem development, and crypto asset management [6][7]. Group 2: Financial Implications - The first project under the new strategy involves the tokenization of FFAI's stock, with an initial plan to purchase $5 million worth of FFAI shares, aiming to achieve lower-cost financing compared to traditional Web2 methods [3][6]. - AIxC is expected to provide five key reverse empowerment benefits to FFAI, including financing, asset enhancement, technological and business support, user expansion, and valuation improvement [7][9]. Group 3: Innovation and Growth - The company has demonstrated its ability to rapidly incubate new businesses, further validating its systematic capability for innovation [9]. - FFAI is focusing on developing an EAI ecosystem and plans to launch its first vehicle in the U.S. by the end of the year, with deliveries in the Middle East scheduled for November 27 [9].

Financial Performance - The Company reported a loss from operations of $206.8 million for Q3 2025, attributed to investments in engineering and strategic initiatives [18]. - The company reported a revenue of $500 million for Q3 2023, representing a 25% increase year-over-year [31]. - The company provided a forward guidance of $600 million in revenue for Q4 2023, indicating a 20% growth compared to Q3 2023 [31]. - The company reported a gross margin of 40%, up from 35% in the previous quarter [31]. - Operating expenses were reduced by 5%, contributing to improved profitability [31]. Product Development and Launch - FX Super One secured over 11,000 non-binding paid pre-orders since its global launch on July 17, 2025 [3]. - The Company finalized its U.S. production assembly plan for FX Super One, entering the trial production phase in Q3 2025 [4]. - FX Super One was launched in the UAE on October 28, 2025, with a price point of approximately $85,000 [9]. - The first U.S. pre-production version of FX Super One is expected to roll off the line by year-end 2025 [22]. - New product launches are expected to contribute an additional $100 million in revenue in the next quarter [31]. Financing and Investment - Financing cash inflow for the nine months ended September 30, 2025, was $135.8 million, a 144% increase from $55.7 million in the same period last year [18]. - Cash on the balance sheet at quarter-end was at the highest level in over two years [5]. - The Company secured $136 million in financing commitments to support its growth strategy and FX Super One launch readiness [14]. - The Company completed a strategic investment of approximately $41 million in Qualigen Therapeutics to enhance its AI technology capabilities [17]. User Growth and Market Expansion - User data showed a growth of 15% in active users, reaching a total of 2 million users [31]. - Market expansion plans include entering three new international markets by the end of 2024 [31]. - A new strategic partnership has been established, projected to increase market share by 10% [31]. - The company is exploring potential acquisitions to enhance its product portfolio and market reach [31]. Operational Developments - FX has established FX Pars in several states, with plans to expand to New Jersey, Florida, and Washington [20]. - The company is investing $50 million in R&D for new technologies aimed at enhancing user experience [31].

Core Insights - Faraday Future (FF) officially launched its first global MPV, the FX Super One, in Dubai, UAE, on October 29 [1] - The AIHER Max version of the FX Super One is priced at 309,000 dirhams [1] - Football star Andrés Iniesta is the first global owner and co-creator of this vehicle [1] - FF introduced an innovative payment model allowing customers to purchase the FX Super One using both fiat currency and cryptocurrency, marking a first in the UAE [1] - Vehicle deliveries in the Middle East are expected to officially commence in November [1]

Core Insights - Qualigen Therapeutics Inc. has announced a strategic partnership with BitGo to support its C10 treasury strategy, which aims to accumulate a market-cap-weighted basket of the world's top 10 crypto assets, excluding stablecoins [1][4]. Group 1: Partnership Details - The partnership will allow Qualigen to utilize BitGo's comprehensive treasury management services, which include access to deep liquidity and secure custody solutions [2][3]. - BitGo's OTC desk will facilitate efficient investments across a diversified basket of 10 digital assets, marking a significant advancement in Qualigen's treasury strategy [2][4]. Group 2: Security and Compliance - Qualigen's treasury assets will be stored securely in regulated cold storage by BitGo, adhering to high security standards and compliance protocols [3][4]. - BitGo's expertise in digital assets will simplify the complexities associated with institutional digital asset adoption, enabling Qualigen to focus on sustainable growth and digital integration [3][4]. Group 3: Strategic Vision - The partnership reflects Qualigen's commitment to financial resilience and leadership in the evolving digital economy, as stated by Co-CEO Jerry Wang [4]. - The $30 million multi-asset allocation signifies growing enterprise confidence in adopting a digital-first treasury strategy [4].

Core Insights - Qualigen Therapeutics, Inc. announced significant leadership and governance changes to enhance its executive team and financial transparency, supporting its strategic growth phase [1] Executive Appointments - Jerry (Jiawei) Wang appointed as Co-Chief Executive Officer and Koti Meka as Chief Financial Officer effective October 2, 2025 [2] - Wang has a background as Global President and founding team member of Faraday Future, involved in raising over $3 billion and leading its IPO in 2021 [2] - Meka previously served as CFO of Faraday Future and has extensive experience at Ford Motor Company in finance roles [3] Board of Directors Expansion and Changes - Following a private placement on September 29, 2025, Qualigen's Board appointed three new members: Chad Chen, Kevin Chen, and Jay Sheng [4] - Jay Sheng has experience as Head of Operations & Finance Director at FF Global Partners LLC and previously served in a senior role at China Aviation Fuel [5] - Kevin Chen is Chief Economist and Chief Investment Officer at Horizon Financial, with board roles in multiple publicly listed companies [6] - Chad Chen is a partner at Yoka | Smith, LLP, with a focus on corporate litigation and business transactions [7] Resignations - Cody Price and Robert Lim resigned from the Board, and Campbell Becher stepped down as Director but remains President; all resignations were amicable [8][9] Auditor Transition - On October 3, 2025, Macias Gini & O'Connell LLP was engaged as the new independent auditor for the fiscal year ending December 31, 2025 [10] - WhitumSmith+Brown, PC resigned as Qualigen's auditor effective October 1, 2025, with no disagreements reported [11] Strategic Outlook - The leadership and governance changes are seen as a crucial step for Qualigen, positioning the company for long-term growth and shareholder value [12] - Qualigen focuses on developing innovative oncology and immunology therapeutics and is exploring crypto and web3 initiatives for global growth [12]

Core Insights - Qualigen Therapeutics (QLGN) shares experienced a significant surge of approximately 200% after securing a $41 million investment from Faraday Future (FFAI) and its founder YT Jia, indicating strong investor enthusiasm for the company's rebranding to CXC10 and its pivot into crypto-Web3 [1][3] - Despite the initial spike, QLGN shares have since retraced much of the gains but remain up nearly 190% from year-to-date lows [2] - The partnership with Faraday, which holds a 55% stake and Jia's additional 7% under a two-year lockup, adds credibility and potential for growth to the newly rebranded CXC10 [3] Financial and Strategic Overview - The pivot towards crypto and Web3 introduces speculative upside, particularly with early gains from the C10 treasury and the promise of AI-driven trading via BesTrade [4] - The transition represents a significant departure from the company's biotech origins, raising concerns about execution and long-term viability [4][5] - Qualigen Therapeutics has a history of operating losses, limited revenue, and a strained balance sheet, which could lead to dilution risks [5][6] Valuation and Market Position - Valuation remains challenging due to the lack of proven product-market fit in the crypto space, with only a 7% gain on its treasury being inconclusive [6] - Regulatory uncertainty, execution risk, and speculative elements contribute to the perception of QLGN stock as a high-risk investment [6]

Company Acquisitions - Pfizer Inc. has agreed to acquire Metsera, Inc. to enhance its portfolio in medicines targeting obesity and cardiometabolic diseases, introducing a range of oral and injectable therapy candidates [2] Stock Market Performance - U.S. stocks showed a mostly positive trend, with the Nasdaq Composite gaining over 50 points, while the Dow increased by 0.01% to 46,321.12, and the S&P 500 rose by 0.15% to 6,674.60 [1] - Information technology shares increased by 0.4%, while consumer staples stocks fell by 0.5% [1] Commodity Market - Oil prices decreased by 0.7% to $62.23, while gold prices increased by 1.3% to $3,752.30. Silver rose by 2.1% to $43.835, and copper fell by 0.4% to $4.6085 [5] Stock Movements - AgriFORCE Growing Systems Ltd. saw a significant increase of 157% to $6.20 following its announcement to rename and raise approximately $550 million [9] - Qualigen Therapeutics, Inc. surged by 141% to $6.86 after a $41 million investment from Faraday Future [9] - MBX Biosciences, Inc. rose by 134% to $23.43 after positive trial results for its product [9] - Chijet Motor Company, Inc. shares dropped by 38% to $0.1813 following the appointment of a new COO [9] - Cosan S.A. shares fell by 23% to $4.3850 after a downgrade from HSBC [9] - Quantum Computing Inc. experienced a decline of 14% to $19.97 after announcing a $500 million private placement [9]

Company Acquisitions - Pfizer Inc. has agreed to acquire Metsera, Inc. to enhance its portfolio in medicines targeting obesity and cardiometabolic diseases, introducing a range of oral and injectable therapy candidates [2] Stock Market Performance - U.S. stocks showed a mostly positive trend, with the Nasdaq Composite gaining over 50 points, while the Dow increased by 0.01% to 46,321.12, and the S&P 500 rose by 0.15% to 6,674.60 [1] - Information technology shares increased by 0.4%, while consumer staples stocks fell by 0.5% [1] Commodity Market - Oil prices decreased by 0.7% to $62.23, while gold prices increased by 1.3% to $3,752.30. Silver rose by 2.1% to $43.835, and copper fell by 0.4% to $4.6085 [5] Stock Movements - AgriFORCE Growing Systems Ltd. saw a significant increase of 157% to $6.20 following its announcement to rename and raise approximately $550 million [9] - Qualigen Therapeutics, Inc. surged by 141% to $6.86 after a $41 million investment from Faraday Future [9] - MBX Biosciences, Inc. rose by 134% to $23.43 after positive Phase 2 trial results for Canvuparatide [9] - Chijet Motor Company, Inc. shares dropped by 38% to $0.1813 after naming a new COO [9] - Cosan S.A. shares fell by 23% to $4.3850 following a downgrade from HSBC [9] - Quantum Computing Inc. decreased by 14% to $19.97 after announcing a $500 million oversubscribed private placement [9]